Today, at the site of the Single Distributor, a meeting was held with the large Spanish equipment manufacturer Dara Pharma.
In pursuance of the instructions of the Head of State to increase the share of local production and strengthen cooperation with foreign manufacturers, the Single Distributor is actively working on issues of attracting world brands to the market of the Republic of Kazakhstan.
Having studied the investment climate in Kazakhstan, Dara Pharma expressed interest in entering our market. As part of today's meeting, the company presented its solution for filling aseptic/sterile packaging for medical purposes (human or veterinary). In addition, it was proposed to develop a biofactory project for presentation to potential investors.
The parties considered ways of cooperation and issues regarding the identification of potential sites and further steps for the implementation of the project. Currently, as part of its work to attract foreign investment, Kazakh Invest is accompanying the Spanish company Dara Pharma.
Today Deta Pharma supplies pharmaceutical packaging machines for the pharmaceutical, biotechnological and cosmetic industries with the most technologically advanced equipment on the market, contributing to the improvement of people's well-being and quality of life.
At the same time, it designs, develops and manufactures packaging equipment for washing, sterilization, filling, freeze drying and capping vials, bottles, syringes, cartridges and intravenous infusion bags for the treatment of liquid, semi-solid products and powders in sterile conditions.
During the dialogue, foreign guests were told about the unified distribution system, contract manufacturing mechanisms, and work with a number of BigPharma companies on projects for the production of innovative drugs with the possibility of exporting to near and far abroad.
The head of the Unified Distributor also focused on the pharmaceutical industry of Kazakhstan and domestic pharmaceutical brands. The Kazakh pharmaceutical industry, thanks to effective government support measures, has enormous potential for profitable investments.
Speaking about investments, the guests were presented with a guide for potential investors – the INVESTMENT GUIDE BOOK, developed jointly with Kazakh Invest, which, according to the principle of "one window", provides a platform for the entry of large pharmaceutical brands into the country from packaging to the full production cycle.
In conclusion, the parties thanked each other for the constructive dialogue and expressed their readiness for fruitful and close cooperation, scheduling a zoom meeting to further work out the issues.
The bilateral partnership will give a dynamic impetus to high-tech production in Kazakhstan, improve the quality of products and services in the field of healthcare, as well as the development of the domestic pharmaceutical industry.
For reference:
«Dara Pharma began its activities in 1996 with a small industrial plant of 250 m² in La Garriga (Barcelona). The first projects were intended for aseptic filling of blood products.
Dara Pharma's international focus is critical to the company as around 97% of its equipment is exported. The sales team, project management and after-sales service operate internationally and are represented in more than 80 countries.»